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The pro-inﬂammatory cytokine IL-1b is a key mediator of inﬂammation and plays an important role in
the host resistance to Mycobacterium tuberculosis infections. To date, most studies have examined the
mechanisms of IL-1b secretion using laboratory strains of M. tuberculosis and the ﬁndings may not be
widely applicable to contemporary clinical strains. Here, we investigated the primary pathways of IL-1b
secretion in macrophages infected with a panel of 17 clinical M. tuberculosis isolates, representing Euro-
American, Indo-Oceanic and East-Asian/Beijing lineages. Our aimwas to dissect the pathways involved in
M. tuberculosis induced IL-1b secretion and to determine whether they are common to all clinical isolates.
We found that the isolates were capable of eliciting variable concentrations of IL-1b from infected murine
macrophages, but this phenomenon could not be attributed to differential IL-1b mRNA transcription or
pro-IL-1b accumulation. We demonstrate that viable bacteria are required to induce IL-1b secretion from
macrophages, but IL-1b secretion was only partially abrogated by caspase-1 inhibition. Almost complete
IL-1b secretion inhibition was produced with combined caspase-1 and some serine protease inhibitors.
Taken together, these ﬁndings demonstrate that clinical strains of M. tuberculosis employ a unique
caspase-1 independent pathway to stimulate IL-1b secretion from macrophages.
 2013 The Authors. Published by Elsevier Ltd. Open access under CC BY license.1. Introduction
Mycobacterium tuberculosis is a complex pathogen capable of
subverting the immune response and establishing life-long
persistent infection in the host.1 Detailed understanding of the
hostepathogen interaction still remains to be delineated. Macro-
phages, the primary host cells for mycobacteria, respond to
M. tuberculosis infection by up regulating a variety of cytokines
including TNF-a, IL-6 and IL-1b. Murine models of tuberculosis
provide compelling evidence for the importance of IL-1b signalling
in the host resistance to M. tuberculosis infection. IL-1 receptor
(IL-1R) and IL-1b knock-out mice are more susceptible to
M. tuberculosis infection, exhibiting high bacterial burden in the
lungs and increased mortality early in infection.2e5x52775; fax: þ44 (0)20 7188
N. Krishnan), b.robertson@
net.com (G. Thwaites).
r Ltd. Open access under CC BY license.The processes involved in the transcription, processing
and release of IL-1b from macrophages are tightly controlled
(summarised in Figure 1). Control of gene expression is mediated
by a number of processes including negative regulation of IL-1b by
type I interferons, which are induced by M. tuberculosis.6,7 The
engagement of pathogen associated molecular patterns (PAMPs)
with pattern recognition receptors (PRRs) such as toll-like re-
ceptors (TLRs) acts as a primary signal leading to the synthesis of
the inactive 31-kDa pro-IL-1b in macrophages.8 Primary signalling
via TLRs is insufﬁcient to stimulate the release of active IL-1b.
Additional microbial danger signals are required for the processing
and release of the mature form of IL-1b. Cleavage of pro-IL-1b into
the biologically active 17 kDa IL-1b protein requires the activation
of the inﬂammasome, a multi-protein complex which stimulates
caspase-1 activation to promote the processing and secretion of
pro-inﬂammatory cytokines. The inﬂammasome provides a plat-
form for the conversion of caspase-1 precursor into its active form
in response to signalling via the nucleotide oligomerization domain
(NOD) receptors and danger associated molecular patterns such as
ATP.9,10 Activated caspase-1 cleaves pro-IL-1b into the mature
biologically active 17 kDa form that is then rapidly secreted out of
the cell via an incompletely understood mechanism. A recent study
Figure 1. Diagram illustrating the different signalling pathways of IL-1b induction in macrophages. The transcription, translation and processing of IL-1b is a highly regulated
process comprising of three major steps: i) synthesis of pro-IL-1b regulated by pattern recognition receptors like TLRs, ii) cleavage of pro-IL-1b by caspase-1 resulting in the mature
form of IL-1b and iii) release of mature IL-1b into the external environment. Activation of the inﬂammasome by secondary signals in the form of microbial ligands, Nigericin, ATP and
other danger signals (e.g. silica, uric acid crystals) induces activation of caspase-1.
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macrophages regulates the processing of pro-IL-1b by directly
acting on the inﬂammasome.11 In other cell types like dendritic
cells, mycobacteria are reported to activate the caspase-8 depen-
dent inﬂammasome.12 The control of processing and secretion of IL-
1b seems to be complex process dependent onmultiple sensors and
effectors.
Several studies have stressed the importance of the mycobac-
terial region of difference-1 (RD-1) locus in modulating the secre-
tion of IL-1b by infected cells.M. marinum DRD-1 andM. bovis BCG
lack functional ESX-1 secretion systems and are impaired in their
ability to induce secretion of mature IL-1b in vitro.13e15 A functional
ESX-1 secretion system has been implicated in the transfer of
bacterial products like the early secreted antigen-6 (ESAT-6), a
known stimulator of caspase-1.16 Effector proteins secreted via the
ESX-1 secretion system are thought to be involved in triggering a
potassium ion efﬂux which is necessary for the activation of
caspase-1 during M. tuberculosis infection.14
The contribution of cell death to the regulation of immune
pathways during M. tuberculosis infection is not clear. Studies have
reported the occurrence of both apoptotic and necrotic cell death
during M. tuberculosis cellular infection. Apoptotic cell death may
limit the spread of intracellular bacteria17,18; while, necrotic cell
death may aid in the escape and dissemination of the bacteria into
new host cells. Induction of necrotic cell death closely correlates
with bacterial burden and virulence of the infectingM. tuberculosis
strain,19,20 with evidence that necrosis may be mediated by ESX-1
activation of the inﬂammasome e NOD-like receptor family, pryin
domain containing 3 (NLRP3).21 Under conditions of extreme in-
ﬂammatory stress, increased levels of cell death contributes toplasma membrane damage which can lead to the rapid release of
bioactive IL-1b from immune cells.22
Increasingly, genetic diversity inM. tuberculosis is understood to
inﬂuence aspects of the hostepathogen interaction, including
virulence, immune modulation and clinical outcomes.23,24 Most
studies to date have examined the mechanisms of IL-1b secretion
using laboratory strains ofM. tuberculosis like H37Rv.5,6,25 Here, we
investigated the primary pathways of IL-1b secretion in macro-
phages infected with a panel of clinical isolates ofM. tuberculosis. In
this study, we report that the ability of M. tuberculosis strains to
induce secretion of IL-1b in murine macrophages is dependent on
both caspase-1 and serine proteases. Additionally, we report that
IL-1b secretion during M. tuberculosis infection is independent of
cell death in infected macrophages.
2. Materials and methods
2.1. Bacterial strains and culture conditions
M. tuberculosis strains were selected using the criteria previ-
ously outlined.23 We selected isolates representative of the three
major lineages including seven East Asian/Beijing strains (strains
119, 345, 212, 649, 374, 333, 411), four Indo-Oceanic strains (strains
346, 232, 372, 281) and six Euro-American strains (strains 293, 173,
355, 318, 440, 639).
Strainswere cultured inMiddlebrook 7H9 liquidmedium (Becton
Dickinson, United Kingdom) supplemented with 0.2% glycerol, 0.05%
Tween 80 and 10% oleic acid-albumin-dextrose-catalase (OADC;
Becton Dickinson, United Kingdom). For growth on solid medium,
Middlebrook 7H10 plates were supplementedwith 0.5% glycerol and
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phase cultures for 20 min before removing from the BSL3 lab.
2.2. Isolation of mouse bone marrow macrophages
Bone marrow cells from 8 to10 week old female BALB/c mice
were isolated and differentiated into macrophages for 7 days in
RPMI 1640 (Lonza, United Kingdom) supplemented with 1 mM
sodium pyruvate (Lonza, United Kingdom), 2 mM L-glutamine
(Lonza, United Kingdom), 0.05 M, 2-mercaptoethanol (Invitrogen,
United Kingdom), 10% heat-inactivated fetal bovine serum (Biosera,
United Kingdom) and 20% L-cell conditioned medium (a kind gift
from Anne O’Garra, MRC National Institute for Medical Research,
London). On day 4, cells were fed with an additional 10 ml of me-
dium. After 7 days in culture, cells were washed with phosphate-
buffered saline (PBS) and seeded into 24-well plates at
5  105 cells/well or in 48-well plates at 2  105 cells/well.
2.3. Cellular infection assays
Macrophages were infected with M. tuberculosis from mid-log
phase cultures at a multiplicity of infection (MOI) of 5. Superna-
tants were removed at 24 and 48 h post-infection and ﬁltered using
0.22 mm ﬁlters (Millipore, United Kingdom) before removing from
the BSL3 lab. Concentration of cytokines in the supernatants was
determined using an enzyme-linked immunosorbent assay (ELISA)
according to the manufacturer’s instructions (E-bioscience, United
Kingdom). Cell death was assayed using the cell death detection
ELISA (Roche Diagnostics, United Kingdom). Brieﬂy, macrophages
were lysed following infection and apoptotic cell death was eval-
uated in the cytoplasmic fractions according to the manufacturer’s
instructions. Intracellular growth of M. tuberculosis was also
determined in the lysed cells, once extracellular bacteria had been
killed by the addition of streptomycin, for strains 411, 212, 333, 281,
232, 372, 355, 293, 318 over 7 days of infection.
For studies using inhibitors, macrophages were stimulated with
the caspase-1 inhibitor, Ac-Tyr-Val-Ala-Asp-2,6-dimethylben-
zoyloxymethyl ketone (Ac-YVAD-AOM; Merck Chemicals, United
Kingdom) at a concentration of 20 mM, serine protease inhibitor,
N-tosyl-L-phenylalanine chloromethylketone (TPCK; Merck Chem-
icals, United Kingdom) at a concentration of 50 mM, N-tosyl-Lys-
Chloromethyl Ketone Hydrochloride (TLCK; Merck Chemicals,
United Kingdom) at a concentration of 50 mM, BAY 11-7082
(NFkB inhibitor) at a concentration of 10 mM, and Nigericin (Sigmae
Aldrich, United Kingdom) at a concentration of 5 mM. Each
M. tuberculosis strain was assayed in triplicate in at least two in-
dependent experiments.
2.4. Real-time PCR
Macrophages were lysed using TRIzol (Invitrogen, United
Kingdom) and total RNA was isolated using Purelink RNA mini kit
(Invitrogen, United Kingdom), according to the manufacturer’s
protocol. cDNAwas generated from1 mg total RNAusing superscript
III reverse transcriptase and random hexamers (Invitrogen, United
Kingdom) according to the manufacturer’s instructions. Reaction
mixtures without reverse transcriptase were used as the negative
control. The reaction mix was incubated at 25 C for 10 min, 50 C
for 30 min, 85 C for 5 min, followed by an incubation at 37 C for
20 min, after the addition of RNase H to terminate the reaction. For
the real-time PCR, each 10 ml reaction mix contained 5 ml TaqMan
universal PCR master mix (Applied Biosystems, United Kingdom),
0.5 ml TaqMan primers and probe, 1 ml cDNA and 3.5 ml of water
(Invitrogen, United Kingdom), as recommended by the manufac-
turer. The reactions were performed on an ABI 7500 real-time PCRthermal cycler (Applied Biosystems, United Kingdom) and the
samples were incubated at 95 C for 20 s, followed by 40 cycles of
95 C for 3 s and 60 C for 30 s. Commercially available primers for
18s and IL-1bwere purchased fromApplied Biosystems and used as
recommended by the manufacturer. Each sample was assayed in
duplicates on two biological replicates. Parallel reactions with no
template controls and reverse transcriptase negative samples were
included in each run. Standard curves were generated to calculate
the relative copy numbers of each gene. For each gene, the calcu-
lated threshold cycle (Ct) of each cytokine transcript was divided by
the Ct of the endogenous control, 18s to obtain a normalised
number for the cytokine transcript for each strain. Fold change for
each gene was calculated relative to the uninfected control. Under
the conditions assayed the levels of 18s was constant and thus was
chosen as the endogenous control.
2.5. Western blots
Macrophages were lysed using RIPA buffer (SigmaeAldrich,
United Kingdom) supplemented with complete protease inhibitor
tablets (Roche Diagnostics, United Kingdom). The samples were
boiled and separated on a 12% polyacrylamide gel (Invitrogen,
United Kingdom) and transferred onto a nitrocellulose membrane
(GE healthcare, United Kingdom). The membrane was probed with
goat polyclonal antibody for pro-IL-1b, mouse monoclonal anti-
body for pro-caspase-1 and mouse monoclonal antibody for
b-actin. All antibodies were sourced from Santa Cruz Biotech-
nology, CA, USA. Stripping of the membrane was carried out using
restore plus western blot stripping buffer (Thermo Fisher Scientiﬁc,
United Kingdom) for subsequent probing with b-actin. Concentra-
tion of total proteinwas determined using the BCA protein assay kit
(Thermo Fisher Scientiﬁc, United Kingdom).
2.6. Statistical analysis
All data are presented as mean  SD of two or three indepen-
dent experiments. Data was combined and analysed using Mann
Whitney U test and a p-value <0.05 was considered statistically
signiﬁcant. Correlation between IL-1b and cell death was per-
formed using the Spearman rank for correlation. All the statistical
tests were performed using Graphpad Prism.
3. Results
3.1. M. tuberculosis clinical isolates induce differential IL-1b
secretion from macrophages
We ﬁrst determined whether M. tuberculosis clinical isolates
vary in their ability to induce IL-1b secretion from macrophages.
Macrophages were infected at a MOI of 5 over 72 h and the con-
centration of IL-1b was determined by ELISA. Strains of
M. tuberculosis differed in their ability to promote secretion of IL-1b,
with a ﬁve-fold difference between the highest and lowest IL-1b
inducers (Figure 2). These differences did not correlate with bac-
terial growth rate within macrophages. Intracellular bacterial
growth was measured in 9 of the strains representative of the ex-
tremes of IL-1b expression, and in two independent experiments.
The growth rates varied between the strains over the ﬁrst 48 h from
2.0 to 8.7  103 CFU/h, but there was no correlation between
growth rate and IL-1b expression (correlation coefﬁcient 0.15,
p ¼ 0.71).
In comparison to clinical isolates ofM. tuberculosis, BCG was less
effective at inducing IL-1b, producing negligible amounts of the
cytokine from macrophages. In addition, we also assessed the role
of bacterial burden in the secretion of IL-1b in strains 293, 212, 318,
Figure 2. M. tuberculosis genotype inﬂuences secretion of IL-1b from macrophages.
Bone marrow macrophages were infected with 17 clinical isolates of M. tuberculosis at
a MOI of 5 for 72 h. Cytokine concentrations in the culture supernatants were deter-
mined by ELISA. Data shown are the means  SD of three independent experiments.
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was effective in stimulating higher concentrations of IL-1b in
comparison to a lower bacterial burden (MOI 1) (data not shown).
The fold increased secretion of IL-1b at aMOI 10 compared toMOI 1
was in the range 1.4e2.2 with a median of 1.8 at 24 h and a fold
increase in the range of 1.3e2.4 with a median of 1.6 at 48 h. The
increase in secretion of IL-1b with MOI was consistent across all
M. tuberculosis isolates tested in this study. Infections at MOI of 1
and 10 induced similar differential pattern of IL-1beta to MOI 5,
although the inter-strain difference in expression was less marked
(data not shown).3.2. M. tuberculosis isolate-dependent IL-1b induction is not due to
altered IL-1b transcription or increased expression of pro-IL-1b
To investigate the possible mechanisms behind the differential
IL-1b expression we subdivided the isolates into those which
induced low, moderate, or high IL-1b levels, based on quartiles
(Figure 2), and selected 3 isolates from each subdivision for further
testing.
We ﬁrst examined whether strains of M. tuberculosis induced
different concentrations of IL-1b through differential interactions
with cell-surface pattern recognition receptors. M. tuberculosis
infected macrophages rapidly transcribed IL-1b mRNA as early as
2 h post-infection (data not shown) and sustained expression
until 24 h (Figure 3A). Additionally, we noted there was no
obvious relationship between the fold increase in IL-1b mRNA
levels and the amount of IL-1b detected by ELISA. Interestingly,
expression of IL-1b mRNA following BCG infection was compa-
rable to some of the clinical M. tuberculosis strains. To determine
whether post-transcriptional control of IL-1b could account for
the observed differences in IL-1b secretion in the supernatants,
we proﬁled the expression of pro-IL-1b in whole cell lysates of
macrophages at 6 h and 24 h post-infection by western blot. We
found that all strains were capable of activating pro-IL-1b in
macrophages (Figure 3B), but pro-IL-1b expression did not differ
signiﬁcantly between strains. These ﬁndings suggest that
genotype-dependent differences in IL-1b expression are not
regulated by differential activation of pattern recognition re-
ceptors but via downstream pathways that mediate either the
caspase-1-dependent or independent conversion of pro-IL-1b to
its active form (Figure 1).3.3. Live bacteria are required to induce optimum IL-1b expression
from macrophages
Next, we tested whether IL-1b secretion is dependent on
live, viable M. tuberculosis. Macrophages were stimulated with
heat-killed mycobacteria and the level of IL-1b protein in the
supernatant was quantiﬁed by ELISA and in the whole cell lysates
by western blots. Dead bacteria were less efﬁcient at stimulating
secretion of mature IL-1b into the supernatants (Figure 4A) and
the differential effect of bacterial genotype on IL-1b expression
was lost. In comparison, the viability of the bacteria had no effect
on the expression of pro-IL-1b in macrophages (Figure 4B).
This suggests that viableM. tuberculosis cells actively modulate pro
IL-1b maturation pathways to control IL-1b secretion in
macrophages.
3.4. M. tuberculosis driven IL-1b secretion is only partially
dependent on caspase-1
We hypothesised that differential IL-1b expression may arise
due to strain-dependent differences in the activation of caspase-1.
First, we compared the expression of pro-caspase-1 between the
isolates and found little difference, with the inactive form of
caspase-1 being constitutively expressed in macrophages
(Figure 5A). We then treated M. tuberculosis infected macrophages
with caspase-1 inhibitor (YVAD) for a period of up to 48 h, which
decreased but did not completely inhibit IL-1b secretion by all the
isolates (Figure 5B and C).
Potassium efﬂux is a common upstream trigger for the activa-
tion of the inﬂammasome, which is required for the activation of
caspase-1.10,26 Therefore, we assessed if the stimulation of an arti-
ﬁcial potassium efﬂux can rescue IL-1b secretion in macrophages
treated with the caspase-1 inhibitor. Macrophages were treated
with Nigericin, a knownpotassium ionophore, and the level of IL-1b
was determined in the culture supernatants. There was increased
secretion of IL-1b from infected macrophages in response to stim-
ulationwith Nigericin at early time points, 6 h (Figure 5B) however,
this trend was no longer observed at 48 h (Figure 5C). Following the
addition of YVAD, there was approximately a 4-fold reduction in
the level of IL-1b release following stimulation of macrophages
with Nigericin (Figure 5B). The addition of Nigericin had no effect
on the secretion of other pro-inﬂammatory cytokines such as TNF-a
fromM. tuberculosis infected macrophages (data not shown). These
data demonstrate that Nigericin induces the secretion of IL-1b by
caspase-1 alone; however, the failure of caspase-1 inhibition to
completely inhibit IL-1b secretion suggests M. tuberculosis may
utilise other caspase-1 independent pathways to induce optimal
secretion of IL-1b from macrophages.
3.5. Some serine protease inhibitors block M. tuberculosis induced
secretion of IL-1b in macrophages
A number of proteases in addition to caspase-1 have been linked
to the maturation of IL-1b including serine proteases, which are
known to be involved in the alternative-processing pathway lead-
ing to the maturation of IL-1b.27 We therefore tested inhibitors of
serine proteases for their capacity to block IL-1b secretion from
M. tuberculosis infected macrophages (Figure 6A). These included
serine protease inhibitors TPCK, TLCK and AEBSF. Some of these
agents can also inhibit NFkB, therefore we also assessed their effect
in comparison to formal NFkB inhibition and TNF-a expression
(Figure 6B). Treatment of macrophages with TPCK following
M. tuberculosis infection led to a signiﬁcant decrease in IL-1b
secretion, especially in the low and moderate IL-1b-expressing
strains (Figure 6A). This level of inhibitionwas further enhanced by
Figure 3. Expression of IL-1bmRNA and pro IL-1b in macrophages is not inﬂuenced by the genotype ofM. tuberculosis. Macrophages were infected withM. tuberculosis at a MOI of 5
and (A) expression of IL-1bmRNA at 6 h and 24 h post-infection was determined using real-time PCR. Fold change represents increased IL-1b transcript expression over uninfected
cells (B) Levels of pro IL-1b was assayed by western blot at 6 h and 24 h in the lysates of M. tuberculosis infected macrophages. For the real-time PCR experiments, data represents
means  SD of two independent experiments.
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reduced the secretion of IL-1b with all the M. tuberculosis isolates
tested (Figure 6A).
The inhibitory effect of TPCK and to a lesser extent TLCK on IL-
1b secretion was partially dependent on NFkB inhibition, as they
also reduced the release of TNF-a from infected macrophages.
However, the inhibitor AEBSF speciﬁcally inhibited release of only
IL-1b (Figure 7A) and not TNF-a (Figure 7B); suggesting AEBSF
may speciﬁcally target an alternative, protease-dependent
pathway of IL-1b expression from M. tuberculosis-infected
macrophages.Figure 4. Heat-killed strains of M. tuberculosis stimulate less IL-1b secretion from macroph
killed strains of M. tuberculosis and BCG for 48 h. IL-1b concentrations in the supernatants
western blot at 6 h and 24 h (B). The cytokine data represents mean  SD of three indepe3.6. IL-1b production in M. tuberculosis infected macrophages does
not correlate with host cell death
Cell death is an effective innate immune response to
M. tuberculosis infection. To measure the association between cell
death and IL-1b release, we quantiﬁed histone associated DNA
complexes in the cytoplasmic fraction to determine apoptosis.
The supernatant from M. tuberculosis infected macrophages was
used to quantify necrotic DNA release by ELISA. Strains of
M. tuberculosis were varied in their ability to cause cell death in
macrophages. However, neither the apoptotic (correlationages than viable bacteria. Bone marrow macrophages were stimulated with nine heat-
were determined by ELISA (A). Levels of pro-IL-1b in the cell lysates were assayed by
ndent experiments.
Figure 5. IL-1b secretion is partially dependent on caspase-1. Macrophages were infected with M. tuberculosis at a MOI of 5 and (A) levels of pro-caspase-1 were measured by
western blot at 6 h and 24 h. Infected macrophages were treated with 20 mM caspase-1 inhibitor (Ac-YVAD-AOM) or treated with 5 mM Nigericin individually or in succession.
Cytokine concentrations for IL-1b was analysed in the supernatants by ELISA at 6 h (B) and 48 h (C). The absolute values of IL-1b are expressed as a fold change over control strains.
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death (correlation coefﬁcient ¼ 0.067 p-value ¼ 0.865) correlated
with the amount of IL-1b released from infected macrophages
(Figure 8A and B).
To examine if the cell death was dependent on caspase-1, we
treated macrophages with a caspase-1 inhibitor and determined
cell death in response to M. tuberculosis infection. We found that
cell death was independent of caspase-1 signalling pathway
(Figure 8C). These results suggest that virulence determinants in
the strains tested are unlikely to contribute to the differential
secretion of IL-1b by manipulating the level of cell death in
macrophages.
4. Discussion
There is substantially more genetic variation amongst clinical
isolates ofM. tuberculosis than previously considered,28 which may
contribute to the longstanding appreciation that some strains are
more virulent than others, although the mechanisms underpinning
this have proved elusive. Macrophages secrete IL-1b in response to
M. tuberculosis infection,2,4 butmost of the publishedwork used the
laboratory strain H37Rv,6,25 which was isolated from a patient with
tuberculosis in 1905 and is therefore of questionable relevance to
currently circulating clinical isolates of M. tuberculosis. Indeed, the
variable ability of clinical isolates of M. tuberculosis to induce IL-1b
secretion from macrophages has not been described.
In this study, we report that clinical isolates of M. tuberculosis
vary in their capacity to induce IL-1b secretion from macrophages
in vitro. In agreement with previous reports our data also suggeststhat IL-1b secretion is dependent on a functional ESX-1 secretion
system since BCG failed to induce IL-1b secretion.6,13,14 An overview
of the panel of screened isolates shows groups of strains that could
induce high, moderate or low levels of IL-1b from macrophages.
The synthesis of pro-IL-1b and the release of its mature form is a
highly regulated multi-step process that includes transcription of
the IL-1b gene and its translation into pro-IL-1b, conversion of pro-
IL-1b into the mature form, which is ﬁnally released into the
external environment.29,30 It has been reported that the primary
pathway of IL-1b induction is regulated at the level of microbial
recognition by PRRs involving TLR2/6 and NOD2 signalling path-
ways.31 Our ﬁndings reveal that all isolates ofM. tuberculosis tested
are able to up regulate the transcription of the IL-1b mRNA in
macrophages, although the levels of the 31 kDa immature form of
IL-1b present are similar. Hence it is likely that the difference noted
in the secretion of active IL-1b is not regulated by PRRs but by
secondary pathways involving the inﬂammasome and caspase-1
activation.
Secretion of IL-1b is dependent on the viability of the bacteria as
heat-killed strains had a substantially reduced capacity to induce
secretion. In contrast, it has been reported by others that both heat-
killed and viableM. tuberculosis H37Rv induced similar levels of IL-
1b from infected peripheral blood mononuclear cells.31 Conversely,
heat-killed M. marinum was impaired in its ability to induce IL-1b
secretion from bone marrow derived macrophages.13 This
discrepancy could be explained by differences in experimental
setup such as of the mycobacteria used, bacterial burden, and the
cell type. Despite these discrepancies, our results strongly support
the idea that live M. tuberculosis actively modulates signalling
Figure 6. Reduced IL-1b and TNF-a secretion from M. tuberculosis infected macrophages in the presence of some serine protease inhibitors. M. tuberculosis infected macrophages
were treated with 50 mM TPCK, 50 mM TLCK and 20 mM caspase-1 individually or in tandem. Cytokine concentrations for IL-1b (A) and TNF-a (B) were analysed in the supernatants
by ELISA at 48 h. The absolute values of cytokines are expressed as a fold change over control strains. Data represents mean  SD of two independent experiments.
Figure 7. The protease inhibitor AEBSF speciﬁcally inhibits IL-1b secretion from M. tuberculosis infected macrophages. M. tuberculosis infected macrophages were treated with
100 mM AEBSF and 20 mM caspase-1 inhibitor. Cytokine concentrations for IL-1b (A) and TNF-a (B) were analysed in the supernatants by ELISA at 48 h. The absolute values of
cytokines are expressed as a fold change over control strains. Data presented is from one experiment only.
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Figure 8. IL-1b secretion from M. tuberculosis infected macrophages does not correlate with cell death. Bone marrow derived macrophages were infected with M. tuberculosis at a
MOI of 5 for 48 h. The amount of necrotic DNA in the cell supernatant (A) and quantity of mono and oligo nucleosomes in the cytoplasmic fraction (B) was determined using ELISA.
Infected macrophages were stimulated with 20 mM caspase-1 inhibitor (YVAD) or treated with 5 mM, Nigericin. After 48 h cell death was measured using ELISA (C). Data represents
mean  SD of three independent experiments.
N. Krishnan et al. / Tuberculosis 93 (2013) 538e547 545pathways downstream of pro-IL-1b formation, to ensure IL-1b
secretion into the external environment.
Caspase-1 is a cysteine protease known to play an important
role in the cleavage of pro-IL-1b to mature IL-1b.32 In our study,
inhibition of caspase-1 led to a decrease in IL-1b production by
macrophages, consistent with previous studies.5,25 However, this
inhibition was only partial suggesting a role for an upstream
caspase-1 independent pathway for optimal secretion of IL-1b.
These ﬁndings suggest an incomplete but vital role for caspase-1 in
the release of IL-1b in vitro. In vivo, caspase-1, ASC and NALP3 are
shown to be dispensable for the host resistance to M. tuberculosis
infection.5,33,34 Hence, it seems likely that caspase-1 independent
pathways play a prominent role in the secretion of IL-1b. An
attempt to rescue the partial inhibition of IL-1b by the addition of
Nigericin, a known inducer of potassium efﬂux in macrophages,
was unsuccessful. Thus, virulent M. tuberculosis activates a potent
potassium efﬂux, which cannot be further enhanced by an external
stimulus. Consequently the observed variability of IL-1b secretion
fromM. tuberculosis-infectedmacrophages cannot be accounted for
by the inability of some isolates to induce a potassium efﬂux.
A marked inhibition of IL-1b release was achieved using the
serine protease inhibitors, TPCK, TLCK and AEBSF. Published reports
show that the inhibitors TPCK and TLCK are also able to block the
activation of NFkB by inhibiting the phosphorylation of IkB.35,36 Our
results support these observations since the addition of TPCK and toa lesser extent TLCK, led to a decrease in TNF-a secretion, which is
also dependent on NFkB activation. Interestingly the protease in-
hibitor AEBSF had no effect on TNF-a secretion fromM. tuberculosis-
infected macrophages, making it plausible that other serine pro-
teases, independent of caspase-1, play a role in the processing of
pro-IL-1b. Further experiments using more targeted approaches
such as siRNA will be required to determine the involvement of
serine proteases in the processing of pro-IL-1b.
Activation of caspase-1 is dependent on a multi-protein struc-
ture, the inﬂammasome, which is activated by microbial ligands
and danger signals. The downstream consequences of inﬂamma-
some activation include release of IL-1b/IL-18 and pyroptosis, a
form of cell death considered to be dependent on caspase-1 acti-
vation.37 We demonstrate that IL-1b secretion is accompanied by
cell death in macrophages during M. tuberculosis infection.
Furthermore, the form of cell death observed in our model was
unlikely to be pyroptosis, as inhibition of caspase-1 by YVAD had no
signiﬁcant effect on the cell death induced in macrophages; an
observation in agreement with previous reports.25,38 Based on our
observation of the enrichment of oligonucleosomes in the cyto-
plasmic fraction of cell lysates, we suggest that it is apoptotic cell
death. Macrophage apoptosis represents a key component of the
host immune response toM. tuberculosis infection, which leads to a
decrease in mycobacterial viability, a mechanism favoured by the
host to remove and clear the pathogen. However, we found
N. Krishnan et al. / Tuberculosis 93 (2013) 538e547546infection of macrophages with M. tuberculosis also led to increased
levels of necrotic DNA in the supernatant. Previous studies have
reported that bacterial burden is a crucial factor that determines
the type of cell death induced in M. tuberculosis infected macro-
phages25,39; it is likely that key factors such as the genetic back-
ground of the infecting bacterial strain also inﬂuence the type of
cell death.40,41 Overall, the ﬁndings suggest that cell death ac-
companies the release of IL-1b but it is unlikely to be the deter-
mining factor for the differential induction of IL-1b observed in
M. tuberculosis infected macrophages.
ESX-1 substrates like ESAT-6 are reported to be involved in the
activation of caspase-1.16 From sequencing analysis, we could not
detect any sequence variation in esxA (Rv3875) or esxB (Rv3874),
the genes encoding ESAT-6 and CFP-10 (unpublished data). This
observation agrees with two recent studies that assessed the ge-
netic diversity in a large collection of clinical isolates of
M. tuberculosis. These studies reported that the lack genetic varia-
tion in esxA and esxB likely conﬁrms the conserved nature of these
proteins.42,43 Consequently, it is unlikely that strain-dependent
differences in IL-1b secretion observed here are due to changes in
EsxA or EsxB.
Enzymes other than caspase-1 have been reported to cleave pro-
IL-1b into the mature form. Neutrophil derived serine proteases,
aspartyl proteases from Candida albicans and cysteine proteases
from Streptococcus pyogenes all directly cleave IL-1b.44,45 Thus, it is
plausible that mycobacterial proteases might also be capable of
processing pro-IL-1b, and future studies will address this
possibility.
In conclusion, we demonstrate that macrophages infected with
a panel of clinical isolates of M. tuberculosis secrete IL-1b. The
pathways that control secretion of IL-1b are dependent on both
caspase-1 and serine proteases. Although cell death is an important
consequence of M. tuberculosis infection of macrophages, it does
not seem to play a role in the differential secretion of IL-1b. Further
delineation of the protease-dependent pathways will provide an
insight into the complex regulatory mechanisms that control IL-1b
secretion in M. tuberculosis infected macrophages.
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